Crescent Biopharma, Inc. Common Stock (CBIO) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for CBIO were recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001253689 (2026-04-11) ↗